Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 8.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Kidney-Pancreas Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 1,335 100.0% 2,906 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 16 1.2% 51 1.8%
OKT3 1 0.1% 10 0.3%
Thymoglobulin 853 63.9% 1,589 54.7%
Zenapax 15 1.1% 218 7.5%
Simulect 40 3.0% 279 9.6%
Campath 278 20.8% 234 8.1%
Rituximab 15 1.1% 12 0.4%
No Induction Drug Reported 168 12.6% 601 20.7%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.